Scientists find clues to mystery of Williams Syndrome’s peculiar symptoms
Patients with Williams Syndrome often are extremely social and possess a remarkable affinity and talent for music. They also experience life-threatening cardiovascular problems and developmental disabilities. The mystery is what happens during development to cause such peculiar symptoms.
Hypertension medication that targets stress may help smokers quit
Smokers trying to quit often light up a cigarette to deal with stress. Now an interdisciplinary team of Yale researchers has shown that guanfacine, a medication approved for treating hypertension that reduces stress and enhances cognition, shows promise as a smoking cessation aid.
New finding suggests a way to block stress’ damage
Ketamine, an anesthetic sometimes abused as a street drug, increases the synaptic connections between brain cells and in low doses acts as a powerful antidepressant, Yale researchers have found. However, stress has the opposite effect, shrinking the number of synaptic spines, triggering depression.
Human cognition depends upon slow-firing neurons, Yale researchers find
Good mental health and clear thinking depend upon our ability to store and manipulate thoughts on a sort of “mental sketch pad.” In a new study, Yale School of Medicine researchers describe the molecular basis of this ability — the hallmark of human cognition — and describe how a breakdown of the system contributes to diseases such as schizophrenia and Alzheimer’s disease.
Smoking Cessation Treatment for Patients With Depression Could Save as Many as 203,000 Lives, YSPH Estimates
A team of scientists estimates that providing patients with depression with the tools to quit smoking could save as many as 125,000 lives over the next 80 years. That number jumps to 203,000 when extended to people with depression who are not yet in mental health care settings.
Trump’s ‘Muslim ban’ harmed health of Muslim Americans, study finds
When former President Donald J. Trump issued an executive order in 2017 banning Muslims from select countries from traveling to the United States, the sweeping decree quickly rippled down to affect health outcomes for Muslim-Americans, Yale researchers say.Source: Yale News
Ivy Shares Experience with Burnout, Depression on Becker's Hospital Review Podcast
Michael Ivy, MD, Deputy Chief Medical Officer at Yale New Haven Health, shares his experience with burnout and depression on this episode and shared advice for executives on supporting clinical staff.Source: Becker's Hospital Review
Researchers at Yale School of Public Health offer free course for users to set self-care goals.
Researchers at the Yale School of Public Health say a free online course that helps users set goals for self-care may significantly improve depression, stress and anxiety. Professor Marney White says the course, Health Behavior Change: From Evidence to Action, is aimed at helping learners find more time for self-care.Source: Connecticut News 12
SLEEP-SMART Intervention Shows Promising Results for Women Suffering from Sleeping Problems, Depression, and Anxiety
Preliminary data indicate SLEEP-SMART can improve sleep patterns, show associated reductions in symptoms of depression and anxiety, and improve the functioning of brain circuits important in emotional and cognitive health.
LGBTQ Community Centers Vital to Mental Health Support, YSPH Finds
In surveys of 60 LGBTQ community centers across the United States, researchers at the Yale School of Public Health found that these venues provide critical frontline mental health services to a population that often faces stigma and a host of other challenges to their emotional well-being.
The Yale Center for Methods in Implementation and Prevention Science Launches Its Global Mental Health Promotion Program, Led by Dr. Theddeus Iheanacho, with an Inaugural Lecture by Dr. Vikram Patel
The Center for Methods in Implementation and Prevention Science (CMIPS) is launching its Global Mental Health Promotion (GMHP) Program to help bridge the gap between knowledge and practice in mental health promotion, especially in low- and middle-income countries (LMICs). Although there is ample evidence for the effectiveness of various interventions for common mental disorders, access to and availability of these interventions remain low. Up to 65% of people in LMICs suffering from mental disorders do not get treatment.